New York Hospital Laboratories — the clinical reference arm of the Department of Pathology and Laboratory Medicine at NewYork-Presbyterian/Weill Cornell Medicine — is one of a select group of U.S. Academic Medical Center Reference Laboratories providing comprehensive pathology and laboratory medicine services to an ever-widening segment of the medical community. We offer a wide range of routine and STAT tests in the following major specialty areas:
- Clinical Chemistry
- Transfusion Medicine and Cellular Therapy
- Routine and special coagulation
- Endocrino
- Routine and special hematology
- Immunochemistry
- erology
- Immunohematology
- Microbiology
- Molecular diagnostics
- Toxicology
- Mycology
- Therapeutic drug monitoring
- Parasitology
- Virology
Individual laboratories are directed by nationally prominent board-certified clinical pathologists and PhD-trained laboratory scientists who supervise more than 350 qualified medical technologists. Chemical, hematological, and immunoassay procedures are performed in a totally automated robotics laboratory, assuring a high degree of precise testing.
Clinical pathologists and scientists are available to provide guidance on test strategies and the interpretation of results. Written interpretative comments are made when necessary and provided as an accompaniment to test results upon request in the following specialty areas of laboratory medicine:
- Biochemical profiling
- Body fluid analysis
- Hemoglobin electrophoresis
- Hemolytic test combinations
- Thrombosis and homeostasis
- Serum/urine electrophoresis
- Serum/urine immunofixation
- Western blot analysis
Specialties
The Clinical Microbiology Laboratory provides infectious disease diagnosis and consultative services for the NewYork-Presbyterian Hospital/Weill Cornell Medicine.
The Coagulation and Hematology Laboratories at New York Presbyterian/Weill Cornell perform and have extensive experience in a wide range of both routine and specialized coagulation/hematology testing for general screening and for diagnostic evaluation of patients with coagulopathies and blood abn